FAGOFARMA
innovation in biotechnology
FAGOFARMA
the future of antibacterial care
FAGOFARMA was founded in 2013.
The main subject of our activity is the development and research of biotechnological preparations based on bacteriophages.
Our goal is to use this promising segment of modern microbiology and transfer it to clinical practice.
The use of bacteriophages is one of the ways to address the burning issue of the dramatic increase in antibiotic resistance and the management of bacterial infections.
RESEARCH
FAGOFARMA's outputs can be used in the research of bacterial resistances in general, as well as in the study and use of plasmids, in alternative biotechnologies and in the construction of antibacterial drugs.
The company's products can potentially also be used in clinical diagnostics.
Research and development activities of FAGOFARMA can be characterized as the preparation of immunobiological phage preparations, realized in three basic directions:
-
phage isolation and specification
-
use of phages to prepare final antibacterial products
-
preparation of phage lysates and special preparations
The isolation and specification of phages is based on the definition of the host bacterial agent strain that the phage isolate obtained destroys.
The phage specification also includes the identification and absence of dangerous components (plasmids), including the genetic characteristics and growth conditions of the phage and host strain.
The final antibacterial products may have the character of active substances (API / DS), medicinal product, disinfectant, etc.
Phage lysates and special preparations contain highly effective virulent phage particles with a polyvalent effect for a given bacterial species.
The preparations can be used in local bacterial infections to destroy cells of the infectious agent.
COOPERATION
FAGOFARMA operates as a contract organization, providing contract research and manufacturing services in the field of microbiology, biotechnology and pharmacy.
Our clients and partners are also other research organizations (both public and private) in the field of immunobiology.
The company is in professional contact with the academic workplaces of universities.